drugset / Trial / NCT07775404

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

NCT07775404 ↗

Phase 3 Recruiting 351 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adult participants living with obesity or overweight with or without T2DM.

Timeline

Start
2026-08-21
Primary completion
2028-04-06
Completion
2028-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Elecoglipron Unknown — Oral

Indications